Circularized Guide RNA for Enhanced Editing Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current RNA-editing technologies face inefficiencies in editing RNA sequences, particularly in terms of synthesis, stability, targeting, and localization of guide RNAs, which hampers their therapeutic potential for diseases.

Innovation Solution

Engineered polynucleotides, such as precursor engineered linear polynucleotides, are designed with targeting domains complementary to specific RNAs and spacer domains that facilitate circularization upon insertion into mammalian cells, enhancing RNA-editing efficiency by stabilizing the guide RNA and recruiting RNA editing enzymes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If linear guide RNA is used for RNA editing, then the structure is simple and easy to synthesize, but the stability and editing efficiency are insufficient

Engineering Contradiction:
Improveease of synthesisVSAvoidediting efficiency
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent applies circularization of the guide RNA structure, transforming the linear form into a closed circular configuration. This curvature eliminates free ends that are susceptible to degradation, thereby enhancing stability while maintaining synthesis feasibility through self-ligation mechanisms or ribozyme-mediated circularization

Inventive Principle:
Principle #14Spheroidality (Curvature)

Solution Approach 2:

The patent creates composite structures by combining the guide RNA with spacer domains and potentially other functional elements to form a circularized composite molecule. This composite approach integrates multiple functions (guiding, stabilizing, and potentially recruiting editing enzymes) into a single enhanced structure

Inventive Principle:
Principle #40Composite materials

2Duration of action of stationary object

If guide RNA is extended to improve stability, then the half-life increases, but the synthesis cost and complexity increase

Engineering Contradiction:
Improvehalf-lifeVSAvoidstructure complexity
Core Design Contradiction:
Duration of action of stationary objectVSDevice complexity

Solution Approach 1:

Circularization provides a compact closed structure that protects the entire molecule from exonuclease degradation without requiring extensive length extensions. The circular topology inherently increases resistance to degradation while maintaining a relatively compact size

Inventive Principle:
Principle #14Spheroidality (Curvature)

Solution Approach 2:

The guide RNA is divided into functional domains (targeting domain, spacer domains, and circularization elements). This segmentation allows each component to perform its specific function while the overall circular structure provides stability, balancing complexity and performance

Inventive Principle:
Principle #1Segmentation

3Reliability

If circularized guide RNA is used, then the stability and editing efficiency are improved, but the design and synthesis process becomes more complex

Engineering Contradiction:
Improveediting efficiencyVSAvoiddesign complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The linear precursor guide RNA is designed with pre-positioned circularization elements (such as complementary overhangs or ribozyme sites) that enable automatic circularization upon entry into the cell. This preliminary arrangement of circularization capabilities in the linear form simplifies the overall design process while achieving the stability benefits of circular structures

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The engineered polynucleotides significantly increase RNA-editing efficiency, stability, and targeting specificity, leading to effective editing of target RNAs and potential therapeutic benefits for diseases like Rett syndrome, Huntington's disease, and others.

Implementation Method 1

hybridization of the targeting domain with the target RNA facilitates an edit of a base of a nucleotide of the target RNA by an RNA editing enzyme

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS20230174977A1Engineered circular polynucleotides
Publication Date: 2023.06.08 SHAPE THERAPEUTICS INC
  • US20230174977A1 patent drawing
  • US20230174977A1 patent drawing
  • US20230174977A1 patent drawing

AI summary

Disclosed herein are engineered guide RNAs, engineered polynucleotides, precursor engineered polynucleotide, vectors omprising engineered polynucleotide, nucleic acids of engineered polynucleotide, pharmaceutical compositions thereof, methods of making the engineered polynucleotides and methods of treating or preventing a disease or condition by administering above described thereof.